Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 15/20 | 0.38 |
| ▸ | ITGAV | P06756 | 13/20 | 0.38 |
| ▸ | ITGB5 | P18084 | 11/20 | 0.38 |
| ▸ | ITGB1 | P05556 | 4/20 | 0.38 |
| ▸ | ITGA5 | P08648 | 4/20 | 0.38 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.38 |
| ▸ | ITGB6 | P18564 | 3/20 | 0.38 |
| ▸ | ITGB8 | P26012 | 3/20 | 0.38 |
| ▸ | MC4R | P32245 | 5/20 | 0.36 |
| ▸ | MC5R | P33032 | 5/20 | 0.36 |
| ▸ | MC3R | P41968 | 5/20 | 0.36 |
| ▸ | MC1R | Q01726 | 5/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14615653 | 0.85 | ITGB3 (0.37) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| SCHEMBL14585790 | 0.83 | ITGB3 (0.36) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| SCHEMBL8365732 | 0.79 | ITGB3 (0.49) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| SCHEMBL14615550 | 0.79 | ITGB3 (0.42) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| SCHEMBL14585789 | 0.78 | ITGB3 (0.47) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| SCHEMBL8363715 | 0.77 | ITGB3 (0.51) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| SCHEMBL14585788 | 0.76 | ITGB3 (0.49) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| SCHEMBL17117494 | 0.74 | ITGB3 (0.51) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| SCHEMBL14585796 | 0.74 | ITGB3 (0.49) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| SCHEMBL8364122 | 0.73 | ITGB3 (0.48) | ITGB3ITGAVITGB5ITGB1ITGA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7179446-B2 | Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2007-02-20 | — | — | US | disclosed |
| US-7179446-B2 | Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2007-02-20 | — | — | US | disclosed |